Welcome to our dedicated page for NEOGEN SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Neogen Corp’s CEO, Nassif Mikheal, reported an indirect open‑market purchase of company stock associated with his son. On February 17, 2026, 23 shares of Neogen common stock were bought at $10.94 per share. Following this trade, 704 shares are reported as indirectly owned "by son." A footnote states that Mikheal disclaims beneficial ownership of these securities, meaning he does not concede that he is their beneficial owner for regulatory or any other purpose.
Neogen Corporation filed a Form 4 detailing small stock purchases made in an account held by the CEO’s son. On 01/26/2026, the son purchased 25 shares of common stock at $9.855 per share, and on 02/02/2026, 24 shares at $9.9997 per share. After these trades, that account held 681 shares. The filing states that CEO Nassif Mikheal reports these holdings indirectly and expressly disclaims beneficial ownership of these securities.
Neogen Corporation reported that a senior vice president received new equity awards on 01/07/2026. The officer was granted 261,210 stock options with a conversion price of $7.38 per share, exercisable until 01/07/2036, covering 261,210 shares of common stock.
In addition, the officer acquired 50,813 shares of common stock linked to options and RSUs and another 50,813 shares tied to PSUs, both at a reference price of $7.38 per share. The options and RSUs vest in three equal annual installments, while the PSUs vest in full at the end of the three-year anniversary of the grant.
Neogen Corporation Senior Vice President Tamara A. Ranalli reported new equity awards. On January 7, 2026, she was granted 130,605 options to acquire Neogen common stock at an exercise price of $7.38 per share, leaving her with 130,605 derivative securities beneficially owned directly. The same day she also acquired 50,813 shares of common stock at a stated price of $7.38 per share, bringing her directly held common stock to 50,813 shares. According to the filing, the options and restricted stock units vest in three equal annual installments on each of the first three anniversaries of the grant date.
Neogen Corporation executive Tamara A. Ranalli filed an initial ownership report as a Senior Vice President of the company. The Form 3 states that no Neogen securities are beneficially owned, meaning she reported holding no direct or indirect shares or derivative securities of the company as of the event date of 01/07/2026.
Neogen Corporation insider reporting shows an indirect purchase of company stock linked to its CEO. On January 16, 2026, an account held by the CEO’s son bought 137 Common Shares of Neogen at $9.3349 per share. After this trade, that account held 632 Common Shares in total. The transaction is reported as indirect ownership "By son", and the reporting person, CEO and director Nassif Mikheal, explicitly disclaims beneficial ownership of these securities.
Neogen Corporation filed a current report to disclose that it has released financial results for its fiscal 2026 second quarter, which ended on November 30, 2025. The company furnished a press release, dated January 8, 2026, as Exhibit 99.1 to provide details about its results of operations and financial condition for this period. The information in this report and the attached press release is being furnished rather than filed, meaning it is not incorporated by reference into other regulatory documents.
Neogen Corp (NEOG) reported an insider transaction on a Form 4. A company insider who is both a Director and CEO reported an open‑market purchase (code P) of 177 common shares at $6.25 on 11/03/2025.
Following this transaction, the filing lists 495 shares beneficially owned, reported as Indirect (I) by son. The filing includes a standard disclaimer that the reporting person disclaims beneficial ownership of these indirectly held securities.
NEOGEN CORP CEO Nassif Mikheal filed an amended Form 3 reporting indirect holdings of company common shares held by his son. The amendment lists two indirect positions of 318 and 302 common shares as of August 11, 2025. A footnote states that Mikheal disclaims beneficial ownership of these securities, meaning he does not acknowledge them as his own holdings for Section 16 or other purposes.